Search
for
Sort by
Research 631–660 of 1000+
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Phytotherapeutic Interventions using Rodent Models of Hair Loss: Current Research and Future Strategy
- 43853 Case of Reactive Keratoacanthomas arising Eight Years After Multicolored Tattoo Placement
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Under Development JAK Inhibitors for Dermatologic Diseases
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Arzneimitteltherapie der Alopezien
- Alopecia areata
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Alopecia Areata: Current Treatments and New Directions
- Topical cyclosporine in male pattern alopecia
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- The most recent advances in understanding and managing hidradenitis suppurativa
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Alopecia areata following COVID-19 vaccine: a systematic review
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Baricitinib for the Treatment of Alopecia Areata
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study